These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro assessment of antidotes to organophosphorus toxicity. Das Gupta S Arch Toxicol Suppl; 1991; 14():3-7. PubMed ID: 1805752 [No Abstract] [Full Text] [Related]
3. Interaction of nerve agent antidotes with cholinergic systems. Soukup O; Tobin G; Kumar UK; Binder J; Proska J; Jun D; Fusek J; Kuca K Curr Med Chem; 2010; 17(16):1708-18. PubMed ID: 20345348 [TBL] [Abstract][Full Text] [Related]
4. Antidotal efficacy of pyridinium oximes and cholineacetyltransferase inhibitors against organophosphorus intoxication in rodents. Dube SN; Kumar D; Acharya J; Dubey DK; Purnanand ; Sikder AK Indian J Physiol Pharmacol; 2000 Jan; 44(1):50-6. PubMed ID: 10919095 [TBL] [Abstract][Full Text] [Related]
5. Pralidoxime rescues both muscarinic and nicotinic systems. Petroianu GA Anesth Analg; 2005 Sep; 101(3):926-927. PubMed ID: 16116023 [No Abstract] [Full Text] [Related]
6. Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds. Sundberg RJ; Dalvie D; Cordero J; Sabat M; Musallam HA Chem Res Toxicol; 1993; 6(4):500-5. PubMed ID: 8374048 [TBL] [Abstract][Full Text] [Related]
7. Carbamate derivatives of 2-arylimidazo[1,2-a]pyridinium salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds. Sundberg RJ; Dalvie D; Cordero J; Musallam HA Chem Res Toxicol; 1993; 6(4):506-10. PubMed ID: 8374049 [TBL] [Abstract][Full Text] [Related]
8. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411. Li B; Schopfer LM; Hinrichs SH; Masson P; Lockridge O Anal Biochem; 2007 Feb; 361(2):263-72. PubMed ID: 17188226 [TBL] [Abstract][Full Text] [Related]
9. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Smirnov I; Belogurov A; Friboulet A; Masson P; Gabibov A; Renard PY Chem Biol Interact; 2013 Mar; 203(1):196-201. PubMed ID: 23123255 [TBL] [Abstract][Full Text] [Related]
10. Quaternary and tertiary aldoxime antidotes for organophosphate exposure in a zebrafish model system. Schmidt HR; Radić Z; Taylor P; Fradinger EA Toxicol Appl Pharmacol; 2015 Apr; 284(2):197-203. PubMed ID: 25701203 [TBL] [Abstract][Full Text] [Related]
11. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides. Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056 [TBL] [Abstract][Full Text] [Related]
12. Organophosphate-induced convulsions and prevention of neuropathological damages. Tuovinen K Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754 [TBL] [Abstract][Full Text] [Related]
13. Improvements in scavenger protection against organophosphorus agents by modification of cholinesterases. Maxwell DM; Saxena A; Gordon RK; Doctor BP Chem Biol Interact; 1999 May; 119-120():419-28. PubMed ID: 10421479 [TBL] [Abstract][Full Text] [Related]
14. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016). Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609 [TBL] [Abstract][Full Text] [Related]
15. A catalytic bioscavenger with improved stability and reduced susceptibility to oxidation for treatment of acute poisoning with neurotoxic organophosphorus compounds. Job L; Köhler A; Escher B; Worek F; Skerra A Toxicol Lett; 2020 Mar; 321():138-145. PubMed ID: 31891759 [TBL] [Abstract][Full Text] [Related]
16. A Study of the Protective Properties of an Antibody-Based Antidote Metabolizing Organophosphorus Pesticide Paraoxon. Mokrushina YA; Stepanova AV; Palikov VA; Stepanov AV; Belous GI; Dyachenko IA; Knorre VD; Smirnov IV; Gabibov AG Bull Exp Biol Med; 2017 Jun; 163(2):218-221. PubMed ID: 28726199 [TBL] [Abstract][Full Text] [Related]
17. Elimination pathways of cyclosarin (GF) mediated by β-cyclodextrin in vitro: pharmacokinetic and toxicokinetic aspects. Kranawetvogl A; Schüler J; Müller S; Thiermann H; Worek F; Reiter G Toxicol Lett; 2013 Oct; 222(2):164-70. PubMed ID: 23906718 [TBL] [Abstract][Full Text] [Related]
18. [The effect of parasympatholytics on the therapeutic effectiveness of the oxime HI-6 against organophosphorus compounds (Soman, substance VX, Fosdrin) in mice]. Kassa J; Vachek J Cas Lek Cesk; 1997 Feb; 136(4):124-6. PubMed ID: 9221183 [TBL] [Abstract][Full Text] [Related]
19. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity. diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006 [TBL] [Abstract][Full Text] [Related]
20. Characterization of natural peptides from bovine tissue using capillary electrophoresis, high performance liquid chromatography, matrix-assisted laser desorption ionization, and Edman degradation. Weiler A; Stoeva S; Lehmann R; Grübler G; Paulus G; Voelter W Electrophoresis; 1996 Mar; 17(3):518-22. PubMed ID: 8740171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]